PSA Surveillance refers to the systematic monitoring of Prostate-Specific Antigen (PSA) levels in the blood, typically used in the context of managing diagnosed prostate cancer or assessing risk in asymptomatic men. While prostate-related, it intersects with androgen receptor activity monitored in hormonal health. We approach this monitoring with necessary caution.
Origin
The term is clinical shorthand, combining the biomarker “Prostate-Specific Antigen” with the process of continuous oversight, “surveillance.” Its use is strongly linked to urology and oncology practice.
Mechanism
PSA is a glycoprotein produced by both normal and malignant prostatic epithelial cells, and its serum concentration often correlates with prostate volume or the presence of prostatic pathology. The mechanism of surveillance involves serial blood draws to track the rate of change (velocity) of PSA, which provides prognostic information regarding disease progression or recurrence following treatment.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.